UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting

Go back to UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
(NYSE: UCB) Delayed: 35.49 -0.56 (1.55%)
Previous Close $36.05    52 Week High
Open $36.20    52 Week Low
Day High $36.30    P/E N/A 
Day Low $35.17    EPS
Volume 1,299,901       

UCB Unsponsored ADR (AMEX: UCBJY) Delayed: 151.41 +4.50 (3.06%)
Previous Close $146.91    52 Week High $46.25 
Open $149.40    52 Week Low $32.74 
Day High $152.00    P/E N/A 
Day Low $148.44    EPS $0.00 
Volume 16,338